A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse : Journal of Cardiovascular Pharmacology

Journal Logo

Drugs in the Pipeline

A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse

Marchetti, Carlo MS*,†,‡; Chojnacki, Jeremy BS§; Toldo, Stefano PhD*,†; Mezzaroma, Eleonora PhD*,†,¶; Tranchida, Nicla MS*,†; Rose, Scott W. BS*,†; Federici, Massimo MD, PhD; Van Tassell, Benjamin W. PharmD*,†,¶; Zhang, Shijun PhD; Abbate, Antonio MD, PhD*,†

Author Information
Journal of Cardiovascular Pharmacology 63(4):p 316-322, April 2014. | DOI: 10.1097/FJC.0000000000000053

Abstract

© 2014 by Lippincott Williams & Wilkins.

You can read the full text of this article if you:

Access through Ovid